期刊文献+

血清胱抑素C和尿白蛋白排泄率与原发性高血压患者早期肾损害的相关分析 被引量:2

血清胱抑素C和尿白蛋白排泄率与原发性高血压患者早期肾损害的相关分析
下载PDF
导出
摘要 目的:分析血清胱抑素C(CysC)和尿白蛋白排泄率(UAER)的联合检测与原发性高血压患者早期肾损害的相关性。方法:用全自动生化分析仪测定286例原发性高血压患者早期肾损害血清胱素C、尿白蛋白、血清肌酐浓度。结果:原发性高血压患者早期损害血清CysC和UAER浓度均高于对照组(P<0.05),两者联合检测的阳性率显著高于单检CysC或单检UAER的阳性率(P<0.01)。结论:原发性高血压患者早期的血清CysC和UAER浓度均显著高于对照组(P<0.05),采用血清CysC和UAER联合检测的阳性检出率较之单项检测显著增加(P<0.01),从而有助于及早发现原发性高血压患者早期肾损害,具有重要的临床诊断意义。 Objective: to analyze the correlation between the joint detection of CysC and UAER and early renal damage in patients with primary hypertension. Method:test concentrations of cysatin C, urinary albumin and serum creatinine of early renal damage in 286 patients with primary hypertension by means of an automatic biochemical analyzer. Result: the concentrations of CysC and UAER of early renal damage in patients with primary hypertension are higher than those in control group ( P 〈 0.05 ) ; the positive rate by joint detection is remarkably higher than that by single detection CysC or UAER ( P 〈 0.01 ). Conclusion: the concentrations of CysC and UAER of early renal damage in patients with primary hypertension are higher than those in control group ( P 〈 0.05 ) ; the positive detection ratio using joint detection of CysC and UAER is apparently increased compared with that using the single detection( P 〈 0. 01 ) ; therefore, it is helpfulto find early renal damage in patients with primary hypertension and is of important clinical significance.
出处 《中国社区医师(医学专业)》 2012年第22期288-289,共2页
关键词 血清胱抑C 尿白蛋白排泄率 原发性高血压 肾早期损害分析 Cystatin C urinary albumin ex-cretion primary hypertension early renaldamage analysis
  • 相关文献

参考文献7

  • 1Hohenstein K, Watschinger B. Hypertension and the kidney. Wien Med Wochenschr, 2008,158 ( 13 - 14) :359 - 364.
  • 2李梦,胡健,方慧娟,樊新,李佳宇.高血压合并糖耐量减低患者血清瘦素水平与尿微量白蛋白的相关性[J].中国动脉硬化杂志,2005,13(5):613-618. 被引量:3
  • 3Taglieri N, Koenig W, Kaski JC. Cystatin C and cardiovascular risk. Clin Chem, 2009,55 (11) :1932 -1943.
  • 4Chaudhary K, Phadke G, Nistala R, et al. The emerging role of biomarkers in diabetic and hypertensive chronic kidney disease. Curt Diab Rep,2010,10(1) :37 -42.
  • 5Prats M, Font R, Bardaj A, et al. Cystatin C and cardiac hyper - trophy in primary hypertension. Blood Press,2010,19 ( 1 ) :20 - 25.
  • 6Palatini P, Benetti E, Zanier A, et al. Cystatim C as predictor of microalbuminuria in the early stage of hypertension. Nephron Clin Pract, 2009,113(4) :309 -314.
  • 7Wu AY, Low LP. Managing vascular risk in hypertension with a focus on microalbuminuria: attitude and practices. Singapore Med J, 2009,50(10) :976 -981.

二级参考文献2

同被引文献17

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部